Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Sun Pharma and Moebius Medical publish clinical and mechanistic data on non-opioid knee…
Phase 2b study and supporting research highlight MM-II’s potential in symptomatic knee osteoarthritis; new findings presented at…
Pharma and healthcare deals in Q1 2025 remain stable amid shift to scalable global models
Grant Thornton Bharat reports 71 transactions totalling USD 2.6 billion in Q1 2025, with investor activity focused on mid-market…
DHL Express and Sai Life Sciences partner to cut emissions in pharma logistics with GoGreen Plus
Sai Life Sciences adopts DHL’s GoGreen Plus service to reduce greenhouse gas emissions by 90 per cent using sustainable aviation…
PHARMAP 2025 brings together global pharma leaders to discuss innovation and drug safety
Chakravarthi AVPS delivers special address on drug safety and moderates key discussion at PHARMAP 2025, shaping the future of…
Cytiva expands portfolio with new MabSelect Resins made from renewable agarose for scalable,…
MabSelect SuRe 70 and MabSelect PrismA X - next-gen Resins redefining affordability and performance in mAb purification
Trump tariffs on the pharmaceutical sector. A new twist- the US department of commerce initiates a…
Ashwin Sapra highlights how the US Section 232 investigation into pharma imports marks a significant escalation in Trump-era trade…
Global divide emerges among physicians over patient choice in biologics vs. biosimilars, reveals…
GlobalData survey uncovers stark regional differences in physician support for patient involvement in choosing between biologics…
PADCEV™ (enfortumab vedotin) now available in India for locally advanced or metastatic urothelial…
Enfortumab vedotin is now available for patients who received prior platinum-containing chemotherapy and a PD-1/L1 inhibitor
Syngene collaborates with biotech firm to develop bile acid modulator for cholestatic disease…
On the occasion of World Liver Day, Jayashree Aiyar, Chief Scientific Officer, Syngene International shared her insights into a…
AbbVie introduces Venetoclax in India for treatment of AML and CLL
On AML World Awareness Day, AbbVie announces its entry into the Indian oncology market with Venetoclax, targeting treatment gaps…